Traders should monitor for actual execution of this sale, as large insider selling by a director and officer may signal lack of confidence, especially amid a pattern of sustained divestment. Consider hedging or reducing exposure ahead of potential downward price pressure.
Price Chart
Executive Summary
Mark A. Goldsmith, a director and officer of Revolution Medicines, intends to sell up to 120,000 shares of common stock, valued at approximately $17.6 million, under a 10b5-1 plan. The sale is scheduled for April 15, 2026, and follows prior 10b5-1 sales by Goldsmith and affiliated trusts totaling over $4.6 million in March 2026.
Key Facts
- Mark A. Goldsmith is a director and officer of Revolution Medicines (RVMDW).
- He filed a Form 144 to sell up to 120,000 shares of common stock, valued at $17,641,200.
- The sale is scheduled for April 15, 2026, under a 10b5-1 plan.
- Goldsmith and affiliated trusts executed over $4.6 million in 10b5-1 sales in early March 2026.
- Total proposed and recent sales by Goldsmith exceed $22 million in the past month.
Financial Impact
$17.6 million in planned insider selling, part of a broader $22+ million divestment trend by the insider and related parties
Risk Factors
- Perceived lack of confidence from insider selling could negatively impact investor sentiment.
- Execution of the sale could increase market supply and contribute to downward price pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003525 |
| Document: 0001950047-26-003525-index.html | 0001950047-26-003525 |
| Document: 0001950047-26-003525.txt | 0001950047-26-003525 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 17, 2026 24w ago | 8-K | $1.88 $9.07 | ▼ −382.45% | ▼ −375.67% | — |
Apr 16, 2026 24w ago | 8-K | $1.88 $8.98 | ▲ +377.66% | ▲ +371.52% | — |
Apr 15, 2026 24w ago | 424B5 | $1.88 $8.96 | ▲ +376.60% | ▲ +369.55% | — |
Apr 15, 2026 24w ago | 424B5 | $1.88 $8.96 | ▼ −376.60% | ▼ −369.55% | — |
Apr 15, 2026 24w ago | 144 | $1.88 $8.96 | ▼ −376.60% | ▼ −369.55% | — |
Apr 13, 2026 24w ago | 424B5 | $1.88 $9.82 | ▼ −422.13% | ▼ −413.61% | — |
Apr 13, 2026 24w ago | 424B5 | $1.88 $9.82 | ▼ −422.13% | ▼ −413.61% | — |
Apr 13, 2026 24w ago | 8-K | $1.88 $9.66 | ▲ +413.83% | ▲ +404.91% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access